1887

Chapter 1 : History of Phage Research and Phage Therapy

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

History of Phage Research and Phage Therapy, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816506/9781555813079_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555816506/9781555813079_Chap01-2.gif

Abstract:

Bacteriophages are widely distributed and exhibit dramatic manifestations both in liquid cultures and on solid media. Félix d’Herelle’s research had two important directions, focusing on (i) the therapeutic use of the phage in infectious diseases and (ii) the biological nature of the bacteriophage itself. From his first studies of clinical samples from dysentery patients, he observed that phage titers rose just as recovery was taking place. The work that attracted the most attention for phage therapy was d’Herelle’s report of the successful treatment of four cases of bubonic plague with an antiplague phage. Phage therapy for cholera seemed to be established as helpful for the treatment of patients with the disease; phage prophylaxis for cholera, however, was less clear-cut. Bacteriophage therapy for patients in hospitals was compared to tetracycline treatment and to fluid replacement alone as a control. In the 1960s, there was a unification of the two main research traditions in genetics, that is, gene transmission and gene expression. Successful investigations of phages and their interactions with host bacteria in natural settings will require both detailed molecular studies and integrated biological research.

Citation: Summers W. 2005. History of Phage Research and Phage Therapy, p 3-17. In Waldor M, Friedman D, Adhya S (ed), Phages. ASM Press, Washington, DC. doi: 10.1128/9781555816506.ch1

Key Concept Ranking

Rous sarcoma virus
0.4850722
Viral Life Cycle
0.4363145
Tobacco mosaic virus
0.42680627
0.4850722
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555816506.chap1
1. Barrow, P.,, M. Lovell,, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab.Immunol. 5: 294 298.
2. Benzer, S. 1955. Fine structure of a genetic region in bacteriophage. Proc. Natl.Acad. Sci.USA 41: 344 354.
3. Bertani, G.,, and J. J. Weigle. 1953. Hostcontrolled variation in bacterial viruses. J. Bacteriol. 65: 113 121.
4. Bruynoghe, R.,, and J. Masin. 1921. Essais de thérapeutique au moyen de bactériophage. C. R. Soc. Biol. Paris 84: 1120 1121.
5. Bryant, R. E.,, J. P. Sanford,, and T. Alcoze. 1965. Treatment of recurrent furunculosis with staphylococcal bacteriophage-lysed vaccine. JAMA 194: 11 14.
6. Cairns, J.,, G. S. Stent,, and J. D. Watson (ed). 1966. Phage and the Origins of Molecular Biology. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
7. Campbell, A. M. 1962. Episomes. Adv. Genet. 11: 101 145.
8. Cislo, M.,, M. Dabrowski,, B. Weber-Dabrowska,, and A. Woyton. 1987. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 35: 175 183.
9. Corbel, M. J.,, and J. A. Morris. 1980. Investigation of the effect of brucella-phage on the course of experimental infection with Brucella abortus. Br. Vet. J. 136: 278 289.
10. Creager, A. N. H. 2002. The Life of a Virus: Tobacco Mosaic Virus as an Experimental Model, 1930-1965. University of Chicago Press, Chicago, Ill.
11. Crick, F. H. C.,, L. Barnett,, S. Brenner,, and R. J. Watts-Tobin. 1961. General nature of the genetic code for proteins. Nature 192: 1227 1232.
12. Delbrück, M. 14 September 1939. Report of research done during the tenure of a Rockefeller Fellowship in 1938 and 1939. Delbrück Papers, item 40.32. Caltech Archives, Pasadena, Calif.
13. Delbrück, M. 1970. A physicist’s renewed look at biology: twenty years later. Science 168: 1312 1315.
14. Delbrück, M. 1978. Oral history, p. 63. Caltech Archives, Pasadena, Calif.
15. Demerec, M.,, and U. Fano. 1945. Bacteriophage-resistant mutants in Escherichia coli. Genetics 30: 119 136.
16. d’Herelle, F. 1917. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. Paris 165: 373 375.
17. d’Herelle, F. 1921. Le Bactériophage: Son Rôle dans l’Immunité, part II, chapter III. Masson, Paris, France.
18. d’Herelle, F. 1925. Essai de traîtement de la pest bubonique par le bactériophage. Presse Méd. 33: 1393 1394.
19. d’Herelle, F. 1926. The Bacteriophage and Its Behavior, p. 117. Williams and Wilkins, Baltimore, Md.
20. d’Herelle, F. 1926. The Bacteriophage and Its Behavior, p. 497. Williams and Wilkins, Baltimore, Md.
21. d’Herelle, F. 1926. The Bacteriophage and Its Behavior, p. 540. Williams and Wilkins, Baltimore, Md.
22. d’Herelle, F. 1926. The Bacteriophage and Its Behavior, p. 541. Williams and Wilkins, Baltimore, Md.
23. d’Herelle, F.,, R. H. Malone,, and M. Lahiri. 1930. Studies on Asiatic cholera. Indian Med. Res. Memoirs 14: 1 161.
24. Duckworth, D. H. 1975. Who discovered bacteriophage? Bacteriol. Rev. 40: 793 802.
25. Eaton, M. D.,, and S. Bayne-Jones. 1934. Bacteriophage therapy. JAMA 103: 1769, 1847, 1934.
26. Elford, W. J.,, and C. H. Andrews. 1932. The sizes of different bacteriophages. Br. J. Exp. Pathol. 13: 446 456.
27. Ellis, E. L. 28 July 1980. Letter to Horace Davenport. Delbrück Papers, item 7.8. Caltech Archives, Pasadena, Calif.
28. Ellis, E. L.,, and M. Delbrück. 1939. The growth of bacteriophage. J. Gen. Physiol. 22: 365 384.
29. Emmerich, R.,, and O. Löw. 1901. Die künstliche Darstellung der immunisierenden Substanzen (Nucleasen-Immunproteïdine) und ihre Verwendung zur Therapie der Infektionskrankheiten und zur Schutzimpfung and Stelle de Heilserums. Z. Hyg. Infektkrankh. 36: 9 36.
30. Fischer, E. P.,, and C. Lipson. 1988. Thinking about Science: Max Delbrück and the Origins of Molecular Biology. Norton, New York,N.Y.
31. Flu, P.-C.,, and E. Renaux. 1932. Le phénomène de Twort et la bactériophage. Ann. Inst. Pasteur 48: 15 18.
32. Greer, G. G.,, and B. D. Dilts. 1990. Inability of a bacteriophage pool to control beef spoilage. Int. J. Food Microbiol. 10: 331 342.
33. Grimont, P. A.,, F. Grimont,, J.Y. Lacut,, A. M. Issanchou,, and J. Aubertin. 1978. Traitement d’une endocardite a Serratia par les bacteriophages. Nouv. Presse Med. 7: 2251.
34. Hankin, E. H. 1896. L’action bactéricide des eaux de la Jumna et du Gange sur le microbe du choléra. Ann. Inst. Pasteur 10: 511 523.
35. Hershey, A. D.,, and R. Rotman. 1949. Genetic recombination between host-range and plaquetype mutants of bacteriophage in single bacterial cells. Genetics 34: 44 71.
36. Kay, L. E. 1985. Conceptual models and analytical tools: the biology of physicist Max Delbrück. J. Hist. Biol. 18: 207 246.
37. Keller, E. F. 1990. Physics and the emergence of molecular biology: a history of cognitive and political synergy. J. Hist. Biol. 23: 389 409.
38. Kucharewicz-Krukowska, A.,, and S. Slopek. 1987. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35: 553 561.
39. Lang, G.,, P. Kehr,, H. Mathevon,, J. M. Clavert,, P. Sejourne,, and J. Pointu. 1979. Bacteriophages et chirurgie orthopedique. A propos de sept cas. Rev. Chir. Orthop. Reparatrice Appar. Mot. 65: 33 37.
40. Lea, D. E. 1946. Actions of Radiations on Living Cells. Cambridge University Press, Cambridge, England.
41. Lederberg, E. M.,, and J. Lederberg. 1953. Genetic studies of lysogenicity in Escherichia coli. Genetics 38: 51 64.
42. Lederberg, J. 1952. Cell genetics and hereditary symbiosis. Physiol. Rev. 32: 403 430.
43. Lederberg, J.,, and E. M. Lederberg. 1952. Replica plating and indirect selection of bacterial mutants. J. Bacteriol. 63: 399 406.
44. Lerondelle, C.,, and B. Poutrel. 1980. Bacteriophage treatment trials on staphylococcal udder infection in lactating cows. Ann. Rech. Vet. 11: 421 426.
45. Leviditi, C.,, and P. Bonet-Maury. 1942. Les ultravirus: considérés à travers le microscope électronique. Presse Méd. 17: 203 207.
46. Lewis, I. M. 1934. Bacterial variation with special reference to behavior of some mutable strains of colon bacteria in synthetic media. J. Bacteriol. 26: 619 639.
47. Loeb, T.,, and N. D. Zinder. 1961. A bacteriophage containing RNA. Proc. Natl. Acad. Sci. USA 47: 282 289.
48. Luria, S. E. 1984. A Slot Machine, a Broken Test Tube. Harper and Row, New York, N.Y.
49. Luria, S. E.,, and T. F. Anderson. 1942. Identification and characterization of bacteriophages with the electron microscope. Proc. Natl. Acad. Sci. USA 28: 127 130.
50. Luria, S. E.,, and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491 511.
51. Luria, S. E.,, and M. L. Human. 1952. A nonhereditary host-induced variation of bacterial viruses. J. Bacteriol. 64: 557 569.
52. Lwoff, A.,, and A. Gutmann. 1950. Recherches sur un Bacillus megathérium lysogène. Ann. Inst. Pasteur 78: 711 739.
53. Maruk, L. M.,, V. N. Nikiforov,, J. F. Šerbak,, T. A. Levitov,, R. I. Kotljarova,, M. S. Naumšia,, S. U. Davydov,, K.A. Monsur,, M. A. Rahman,, M. A. Latif,, R. S. Northrup,, R. A. Cash,, I. Huq,, C. R. Dey,, and R. A. Phillips. 1971. Clinical studies of the use of bacteriophage in the treatment of cholera. Bull. W.H.O. 45: 77 83.
54. Meitert, E.,, M. Petrovici,, F. Sima,, G. Costache,, and C. Savulian. 1987. Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa. Arch. Roum. Pathol. Exp. Microbiol. 46: 17 26.
55. Monsur, K. A.,, M. A. Rahman,, F. Huq,, M. N. Islam,, R. S. Northrup,, and N. Hirschhorn. 1970. Effect of massive doses of bacteriophage on excretion of vibrio, duration of diarrhoea and output of stools in acute cases of cholera. Bull. W.H.O. 42: 723 732.
56. Morange, M. 2002. Les mousquetaires de la nouvelle biologie: Monod, Jacob, Lwoff. Pour Science 10: 3 52.
57. Mulczyk, M.,, and S. Slopek. 1974. Use of a new phage preparation in prophylaxis and treatment of shigellosis. Acta Microbiol. Acad. Sci. Hung. 21: 115 119.
58. Muller, H. J. 1922. Variations due to change in the individual gene. Am. Nat. 56: 48 49.
59. Nakai, T.,, R. Sugimoto,, K. H. Park,, S. Matsuoka,, K. Mori,, T. Nishioka,, and K. Maruyama. 1999. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis. Aquat. Organ. 37: 33 41.
60. Otto, R., and H. Munter. 1923. Bacteriophagie. Ergeb. Hyg. Bakteriol. Immun. Exp. Ther. 6: 1 50.
61. Park, S. C.,, I. Shimamura,, M. Fukunaga,, K. I. Mori,, and T. Nakai. 2000. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl. Environ. Microbiol. 66: 1416 1422.
62. Pfankuch, E.,, and G. A. Kausche. 1940. Isolierung und übermikroskopische Abbildung eines Bakteriophagen. Naturwissenshaften 28: 46.
63. Pillich, J.,, J. Tovarek,, and M. Fait. 1978. Ein Beitrag zur Behandlung der akuten hamatogenen und chronischen sekundaren Osteomyelitiden bei Kindern. Z. Orth. Ihre Grenzgeb. 116: 40 46.
64. Radetsky, P. 1996. The good virus. Discover 1996( November): 50 58.
65. Reynaud, A.,, L. Cloastre,, J. Bernard,, H. Laveran,, H. W. Ackermann,, D. Licois,, and B. Joly. 1992. Characteristics and diffusion in the rabbit of a phage for Escherichia coli O103.Attempts to use this phage for therapy. Vet. Microbiol. 30: 203 212.
66. Ruska, H. 1940. Die Sichtbarmachung der bakteriophagen Lyse im Ubermikroskop. Naturwissenshaften 28: 45 46.
67. Schlesinger, M. 1936. The Feulgen reaction of the bacteriophage substance. Nature 138: 508 509.
68. Sertic, V.,, and N. Boulgakov. 1935. Classification et identification des typhiphages. C. R. Soc. Biol. Paris 119: 1270 1272.
69. Shera, G. 1970. Phage treatment of severe burns. Br. Med. J. 1: 568 569.
70. Slopek, S.,, I. Durlakowa,, B. Weber-Dabrowska,, M. Dabrowski,, and A. Kucharewicz-Krukowska. 1984. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. Arch. Immunol. Ther. Exp. 32: 317 335.
71. Slopek, S.,, I. Durlakowa,, B. Weber-Dabrowska,, A. Kucharewicz-Krukowska,, M. Dabrowski,, and R. Bisikiewicz. 1983. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol.Ther. Exp. 31: 267 291.
72. Slopek, S.,, I. Durlakowa,, B. Weber-Dabrowska,, A. Kucharewicz-Krukowska,, M. Dabrowski,, and R. Bisikiewicz. 1983. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp. 31: 293 327.
73. Slopek, S.,, A. Kucharewicz-Krukowska,, B. Weber-Dabrowska,, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp. 33: 219 240.
74. Slopek, S.,, A. Kucharewicz-Krukowska,, B. Weber-Dabrowska,, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch .Immunol .Ther. Exp. 33: 241 259.
75. Slopek, S.,, A. Kucharewicz-Krukowska,, B. Weber-Dabrowska,, and M. Dabrowski. 1985. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. 33: 261 273.
76. Slopek, S.,, B. Weber-Dabrowska,, M. Dabrowski,, and A. Kucharewicz-Krukowska. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35: 569 583.
77. Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 37: 258 261.
78. Stahl, F. (ed.). 2000. We Can Sleep Later:Alfred D. Hershey and the Origins of Molecular Biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
79. Stent, G. S. 1963. Molecular Biology of Bacterial Viruses, p. 18. Freeman, San Francisco, Calif.
80. Summers, W. C. 1991. From culture as organism to organism as cell: historical origins of bacterial genetics. J. Hist. Biol. 24: 171 190.
81. Summers, W.C. 1993. How bacteriophage came to be used by the Phage Group. J. Hist. Biol. 26: 255 267.
82. Summers, W. C. 1993. Plague and cholera in India: the bacteriophage inquiry of 1928-1936. J. Hist. Med. Allied Sci. 48: 275 301.
83. Summers, W. C., 1998. Theorien der Verursachung, ihre Rechtfertigung und de experimentelle Wissenschaft: Daniel E. Salmon und die Schweinepest, p. 77 92. In C. Gradmann, and T. Schlich (ed.), Strategien der Kausalitaet. Konzeptionen der Krankheitsversursachung im 19 und 20 Jahrhundert. Centaurus, Pfaffenweiler, Germany.
84. Summers, W.C. 1999. Félix d’Herelle and the Origins of Molecular Biology. Yale University Press, New Haven, Conn.
85. Timofeev-Ressovsky, N. W.,, K. G. Zimmer,, and M. Delbrück. 1935. Über die Natur der Genmutation und der Genstruktur. Nachr. Ges. Wiss. Göttingen Math.-Phys. Kl. 6: 189 243.
86. Twort, A. 1993. In Focus, Out of Step: A Biography of Frederick William Twort, F.R.S., 1877-1950. Alan Sutton, Dover, N. H.
87. Twort, F.W. 1915. An investigation on the nature of ultra-microscopic viruses. Lancet ii: 1241 1243.
88. van Helvoort, T. 1985. Felix d’Herelle en de controverse rond het Twort-d’Herelle Fenomeen in de jaren 1920: ultrafiltreerbarr virus of lytisch ferment. Tijdschr. Geschied. Geneeskd. Natuurwet .Wiskd. Tech. 9: 118 131.
89. Vieu, J. F.,, F. Guillermat,, R. Minck,, and P. Nicolle. 1979. Donnees actueles sur les applications therapeutiques des bacteriophages. Bull. Acad. Natl. Med. 163: 61.
90. Volkin, E.,, and L. Astrachan. 1956. Phosphorus incorporation in Escherichia coli ribonucleic acid after infection with bacteriophage T2. Virology 2: 149 161.
91. Watson, J. D., 1966. Growing up in the phage group, p. 239 245. In J. Cairns,, G. S. Stent,, and J. D. Watson (ed.), Phage and the Origins of Molecular Biology. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
92. Weber-Dabrowska, B.,, M. Dabrowski,, and S. Slopek. 1987. Studies on bacteriophage penetra- tion in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35: 563 568.
93. Weber-Dabrowska, B.,, M. Zimecki,, and M. Mulczyk. 2000. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48: 31 37.
94. Williams Smith, H.,, and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 128: 307 318.
95. Williams Smith, H.,, and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129: 2659 2675.
96. Williams Smith, H.,, M. B. Huggins,, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133: 1111 1126.
97. Williams Smith, H.,, M. B. Huggins,, and K. M. Shaw. 1987. Factors influencing the survival and multiplication of bacteriophages in calves and their environment. J. Gen. Microbiol. 133: 1127 1135.
98. Wittig, H. J.,, J. F. Raffetto,, and R. Bason. 1966. Bacteriophage therapy in infective childhood asthma. JAMA 196: 435.
99. Wollman, E.,, and E. Wollman. 1937. Les phases de bactériophages (facteurs lysogènes). C.R. Soc. Biol. Paris 124: 931 934.
100. Wollman, E.,, F. Holweck,, and S. Luria. 1940. Effect of radiations on bacteriophage C16. Nature 145: 935 936.
101. Zilisteanu, C.,, H. Ionescu,, T. Ionescu-Dorohoi,, O. Coman,, M. Badescu,, and V. Brinzac. 1973. L’utilisation du bacteriophage dans la prophylaxie et le traitement de la dysenterie bacillaire. Arch. Roum. Pathol. Exp. Microbiol. 32: 193 198.
102. Zilisteanu, C.,, H. Ionescu,, T. Ionescu-Dorohoi,, and L. Mintzer. 1971. Considerations sur le traitement des infections urinaires par l’association bacteriophage-autovaccin-antibiotiques. Arch. Roum. Pathol. Exp. Microbiol. 30: 195 207.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error